nmdp logo

How NMDP BioTherapies is Transforming Cellular Therapy in Transplant Centers

On-demand panel discussion link


NMDPSM BioTherapies®what's that? In this session, learn how NMDP is supporting cell therapy in transplant centers today and into the future.

Learning Objectives

  • Developments in the cell and gene therapy field and how that will impact transplant centers
  • How the NMDP is extending its expertise to support clinical trials in transplant centers and across the cell and gene therapy industry
  • How the NMDP can help advocate for your teams as more cell therapies move into the clinic and become commercially available
  • Review challenges and opportunities in onboarding and working on clinical trials in transplant centers

Target Audience

Coordinators, physicians, medical directors


  • Joy Aho, PhD, Serior Product Manager, NMDP
  • Jeffery Auletta, MD, SVP, Patient Outcomes & Experience, NMDP & Chief Scientific Director, CIBMTR® (Center for International Blood and Marrow Transplant Research®)
  • Makensie Becker, Client Success Manager, NMDP BioTherapies
  • Eric Davis, MPH, CHTC, Program Manager, BMT Unrelated Donor Search Program, Memorial Sloan Kettering
  • Jamey Hardesty, MPH, Clinical Operations Partner, NMDP